Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. - Bernard-Marty,C.; Mano,M.; Paesmans,M.; Accettura,C.; Munoz-Bermeo,R.; Richard,T. (Ann Oncol, 2003)